Fig. 2From: Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarctionPrimary endpoint in the three study groups, after propensity score matching. Composite of in-hospital mortality, acute heart failure, and acute kidney injury requiring renal replacement therapy in patients without diabetes mellitus and in those with diabetes mellitus treated or not with GLP-1 RA/SGLT-2i. AKI acute kidney injury, DM diabetes mellitus, GLP-1 RA glucagon-like peptide-1 receptor agonists, RRT renal replacement therapy, SGLT-2i sodium glucose cotransporter-2 inhibitorsBack to article page